NRXS
NeurAxis, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.96
−1.81%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-12.9%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 26, 2026 | Carrico Brian Allen · director, officer: Chief Executive Officer | A-Award | 199,188 | $0.00 |
| Aug 26, 2026 | Miranda Adrian · officer: CMO, SVP Science & Tech | A-Award | 337,204 | $0.00 |
| Aug 26, 2026 | Miranda Adrian · officer: CMO, SVP Science & Tech | A-Award | 199,106 | $0.00 |
| Aug 26, 2026 | Carrico Thomas Joeseph · officer: CRO, CCO, CPO | A-Award | 306,236 | $0.00 |
| Aug 26, 2026 | Carrico Thomas Joeseph · officer: CRO, CCO, CPO | A-Award | 193,678 | $0.00 |
| Aug 26, 2026 | Carrico Brian Allen · director, officer: Chief Executive Officer | A-Award | 320,000 | $0.00 |
| Aug 17, 2026 | Aharon Gil · director | A-Award | 40,068 | $0.00 |
| Aug 17, 2026 | Miranda Adrian · officer: CMO, SVP Science & Tech | A-Award | 133,341 | $0.00 |
| Aug 17, 2026 | Watkins Bradley Mitchell · director | A-Award | 26,073 | $6.28 |
| Aug 17, 2026 | Aharon Gil · director | A-Award | 43,930 | $6.28 |
| Aug 17, 2026 | Aharon Gil · director | A-Award | 2,226 | $0.00 |
| Aug 17, 2026 | Carrico Brian Allen · director, officer: Chief Executive Officer | A-Award | 193,329 | $0.00 |
| Aug 17, 2026 | Carrico Thomas Joeseph · officer: CRO, CCO, CPO | A-Award | 135,906 | $0.00 |
| Aug 17, 2026 | Ferge Kristin A · director | A-Award | 31,134 | $6.28 |
| Aug 17, 2026 | Henrichs Timothy Robert · officer: Chief Financial Officer | A-Award | 141,479 | $0.00 |
| Aug 17, 2026 | Keyser Jane Elizabeth · director | A-Award | 26,073 | $6.28 |
| Apr 30, 2026 | Aharon Gil · director | A-Award | 12,304 | $0.00 |
| Apr 30, 2026 | Aharon Gil · director | A-Award | 221,917 | $0.00 |
| Apr 3, 2026 | Carrico Brian Allen · director, officer: Chief Executive Officer | Purchase | 8,060 | $1.96 |
| Apr 3, 2026 | Henrichs Timothy Robert · officer: Chief Financial Officer | Purchase | 7,593 | $1.96 |
| Apr 3, 2026 | Carrico Thomas Joeseph · officer: CRO, CCO, CPO | Purchase | 667 | $1.96 |
| Mar 2, 2026 | Miranda Adrian · officer: CMO, SVP Science & Tech | A-Award | 47,569 | $0.00 |
| Feb 26, 2026 | Carrico Thomas Joeseph · officer: CRO, CCO, CPO | A-Award | 47,569 | $0.00 |
| Feb 26, 2026 | Watkins Bradley Mitchell · director | A-Award | 21,598 | $4.63 |
| Feb 26, 2026 | Keyser Jane Elizabeth · director | A-Award | 21,598 | $4.63 |
| Feb 26, 2026 | Henrichs Timothy Robert · officer: Chief Financial Officer | A-Award | 75,231 | $0.00 |
| Feb 26, 2026 | Carrico Brian Allen · director, officer: Chief Executive Officer | A-Award | 94,173 | $0.00 |
| Jan 30, 2026 | Aharon Gil · director | A-Award | 21,598 | $4.63 |
| Jan 30, 2026 | Ferge Kristin A · director | A-Award | 21,598 | $4.63 |
| Dec 29, 2025 | Aharon Gil · director | Purchase | 286,138 | $3.52 |
Institutional positioning
13F filings over the trailing two quarters
New 13Increased 4Reduced 4Sold out 26
| Filer | Action | Shares | Filed |
|---|---|---|---|
| AIGH CAPITAL MANAGEMENT LLC | Unchanged | 400,000 | Apr 30, 2026 |
| ROSALIND ADVISORS, INC. | Unchanged | 286,138 | May 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 225,867 | May 15, 2026 |
| MONEY CONCEPTS CAPITAL CORP | Increased | 225,555 | Apr 30, 2026 |
| PANORAMIC CAPITAL, LLC | Increased | 190,000 | May 15, 2026 |
| PARSONS CAPITAL MANAGEMENT INC/RI | Unchanged | 116,726 | Apr 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 93,105 | May 15, 2026 |
| CITADEL ADVISORS LLC | New Position | 85,053 | Sep 2, 2026 |
| MARSHALL WACE, LLP | New Position | 78,695 | May 15, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | New Position | 76,954 | May 14, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 51,887 | May 8, 2026 |
| CENTIVA CAPITAL, LP | New Position | 50,833 | May 14, 2026 |
| UBS GROUP AG | Reduced | 45,342 | May 5, 2026 |
| STATE STREET CORP | Increased | 38,537 | May 15, 2026 |
| T3 Companies, LLC | New Position | 29,921 | May 7, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 26, 2026